Adcock Ingram Holdings Limited (AIP.JO)
- Previous Close
5,550.00 - Open
5,550.00 - Bid --
- Ask --
- Day's Range
5,550.00 - 5,587.00 - 52 Week Range
4,958.00 - 6,148.00 - Volume
18,788 - Avg. Volume
77,191 - Market Cap (intraday)
8.411B - Beta (5Y Monthly) 0.31
- PE Ratio (TTM)
10.14 - EPS (TTM)
5.49 - Earnings Date Feb 21, 2024
- Forward Dividend & Yield 2.50 (4.49%)
- Ex-Dividend Date Mar 13, 2024
- 1y Target Est
56.00
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products in oral solid dosage formulations, syrups, intravenous, and injectable dosage forms. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides renal healthcare services. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
www.adcock.co.za--
Full Time Employees
June 30
Fiscal Year Ends
Sector
Related News
Performance Overview: AIP.JO
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AIP.JO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AIP.JO
Valuation Measures
Market Cap
8.41B
Enterprise Value
8.78B
Trailing P/E
10.14
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.96
Price/Book (mrq)
1.54
Enterprise Value/Revenue
0.96
Enterprise Value/EBITDA
7.02
Financial Highlights
Profitability and Income Statement
Profit Margin
9.51%
Return on Assets (ttm)
8.63%
Return on Equity (ttm)
15.96%
Revenue (ttm)
9.2B
Net Income Avi to Common (ttm)
874.23M
Diluted EPS (ttm)
5.49
Balance Sheet and Cash Flow
Total Cash (mrq)
107.14M
Total Debt/Equity (mrq)
8.77%
Levered Free Cash Flow (ttm)
696.26M
Research Analysis: AIP.JO
Company Insights: AIP.JO
AIP.JO does not have Company Insights